Evidence map›Paper›PMID 42593102›Full record

ArticlemBio2026

Mucin promotes Psl production and surface exploration in

Sabrina I Lamont, Matthew J Pestrak, Matthew R Parsek, Katharina Ribbeck, Daniel J Wozniak

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in mBio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Sabrina I LamontDepartment of Microbiology, Ohio State University, Columbus, Ohio, USA.ORCID 0000-0001-8954-7683
Matthew J PestrakDepartment of Microbial Infection and Immunity, Ohio State University College of Medicine, Columbus, Ohio, USA.ORCID 0000-0002-7609-7537
Matthew R ParsekDepartment of Microbiology, University of Washington School of Medicine, Seattle, Washington, USA.
Katharina RibbeckDepartment of Biological Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
Daniel J WozniakDepartment of Microbiology, Ohio State University, Columbus, Ohio, USA.ORCID 0000-0003-4592-4816

Funding

Translational Therapeutics Research Program (TT)P30CA016058 · NCI · OHIO STATE UNIVERSITY · PI Tasleem J Padamsee · 1985 to 2026
$132.3M
Cooperation and antagonism in polymicrobial infectionR01AI186380 · NIAID · OHIO STATE UNIVERSITY · PI MATTHEW R. PARSEK, Daniel J Wozniak · 2024 to 2026
$2.2M
Molecular determinants and functions of bacterial polysaccharide cellular localizationR01AI183692 · NIAID · UNIVERSITY OF WASHINGTON · PI Patricia Lynne Howell, MATTHEW R. PARSEK · 2025 to 2026
$1.5M
Cloned pigs for XenotransplantationR41AI069865 · NIAID · EVERGEN BIOTECHNOLOGIES, INC. · PI YANG, XIANGZHONG · 2006 to 2006
$166k
Cystic Fibrosis Foundation McCoy24NCI NIH HHS P30 CA016058NIAID NIH HHS R01 AI183692NIAID NIH HHS R01 AI186380NIAID NIH HHS R41 AI069865NIH HHS CCSG P30CA016058NIH HHS R01AI186380NIH HHS R01AI69865
6 · The paper itself

Abstract

In chronic, recalcitrant infections,

Indexed as

MucinsPolysaccharides, BacterialPseudomonas aeruginosaAnimalsBiofilmsSwineexopolysaccharide, PseudomonasMucinsPolysaccharides, BacterialbiofilmsmucinPslsurface explorationtwitching

Identifiers

PMID42593102
PMCPMC13556220

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.